ILM peeling improves outcomes in FTMH

Article

According to Prof. Lois, peeling the internal limiting membrane when operating on patients with idiopathic full-thickness macular hole improves the outcomes of surgery. This article reviews her recent review study and highlights the outcomes.

Related Videos
Kasperi Kankare at the iCare booth at ESCRS
Colman Cawe, director of fundraising and communications, Orbis UK
The slide reads, "ASRS 2023. What research do you find exciting or interesting? Hear what presenters and industry leaders have to say about the presentations at ASRS 2023."
The slide reads, "ASRS 2023. What research do you find exciting or interesting? Hear what presenters and industry leaders have to say about the presentations at ASRS 2023."
The slide reads, "ASRS 2023. What research do you find exciting or interesting? Hear what presenters and industry leaders have to say about the presentations at ASRS 2023."
Maria H. Berrocal, MD, speaks on a virtual call before the Women in Ophthalmology symposium in Marco Island, Florida
Fernando Arevalo, MD, PhD, FACS, FASRS, stands against a backdrop as he is interviewed at the 2023 ASRS annual meeting.
Related Content

Industry-sponsored satellite symposia at the 23rd EURETINA Congress

September 27th 2023

23rd annual EURETINA Congress: seeing eye to eye in Amsterdam

September 25th 2023

RETFound: New AI model to detect retinal disease biomarkers developed by Moorfields Eye Hospital

September 14th 2023

ESCRS 2023: Ace Vision Group presents scientific data focused on laser scleral microporation

September 9th 2023

Orbis and Heidelberg Engineering announce new partnership at ESCRS congress

September 8th 2023

Impact of personalised faricimab dosing in neovascular AMD

September 7th 2023

Industry-sponsored satellite symposia at the 23rd EURETINA Congress

September 27th 2023

23rd annual EURETINA Congress: seeing eye to eye in Amsterdam

September 25th 2023

RETFound: New AI model to detect retinal disease biomarkers developed by Moorfields Eye Hospital

September 14th 2023

ESCRS 2023: Ace Vision Group presents scientific data focused on laser scleral microporation

September 9th 2023

Orbis and Heidelberg Engineering announce new partnership at ESCRS congress

September 8th 2023

Impact of personalised faricimab dosing in neovascular AMD

September 7th 2023

Industry-sponsored satellite symposia at the 23rd EURETINA Congress

September 27th 2023

23rd annual EURETINA Congress: seeing eye to eye in Amsterdam

September 25th 2023

RETFound: New AI model to detect retinal disease biomarkers developed by Moorfields Eye Hospital

September 14th 2023

ESCRS 2023: Ace Vision Group presents scientific data focused on laser scleral microporation

September 9th 2023

Orbis and Heidelberg Engineering announce new partnership at ESCRS congress

September 8th 2023

Impact of personalised faricimab dosing in neovascular AMD

September 7th 2023
© 2023 MJH Life Sciences

All rights reserved.